STANFORD UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-11-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.stanford.edu
Electrical Stimulation as an Adjunctive Therapy to Increase Vascular Perfusion in People With PAD or PVD
Not Applicable
Terminated
- Conditions
- PVD- Peripheral Vascular DiseasePAD - Peripheral Arterial Disease
- Interventions
- Device: Tennant Biomodulator-Pro™ Device
- First Posted Date
- 2020-03-18
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 4
- Registration Number
- NCT04313985
- Locations
- 🇺🇸
Stanford Advanced Wound Care Center, Redwood City, California, United States
Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure
Active, not recruiting
- Conditions
- Blast or Combat ExposureHead Injury Trauma
- Interventions
- Drug: ibogaine with magnesium treatment
- First Posted Date
- 2020-03-18
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 30
- Registration Number
- NCT04313712
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Serratus Anterior Plane Block for Improving Pain and Respiratory Function in Patients With Multiple Rib Fractures
Completed
- Conditions
- Rib Fracture Multiple
- Interventions
- Other: Serratus Anterior Plane Block
- First Posted Date
- 2020-03-17
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 39
- Registration Number
- NCT04311827
- Locations
- 🇺🇸
Stanford University Hospital, Palo Alto, California, United States
Transcranial Direct Current to Treat Epilepsy at Home
Early Phase 1
- Conditions
- Epilepsies, Partial
- Interventions
- Device: transcranial direct current stimulation (tDCS)
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 30
- Registration Number
- NCT04309812
- Locations
- 🇺🇸
Stanford Hospital, Stanford, California, United States
🇺🇸Stanford University School of Medicine, Stanford, California, United States
Neuroimaging GABA Physiology in Fragile X Syndrome
Phase 1
Terminated
- Conditions
- Fragile X Syndrome (FXS)Idiopathic Intellectual Developmental Disorder (IDD)
- Interventions
- Drug: [18F]flumazenil
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 17
- Registration Number
- NCT04308954
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
Effects of Mindfulness Training on Burnout and Mood in Hospital Employees
Not Applicable
Completed
- Conditions
- BurnoutAnxiety Depression
- Interventions
- Behavioral: Mindfulness session
- First Posted Date
- 2020-03-13
- Last Posted Date
- 2022-12-12
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 52
- Registration Number
- NCT04307563
- Locations
- 🇺🇸
Stanford Health Care, Palo Alto, California, United States
Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment
Not Applicable
Completed
- Conditions
- Pancreatic Adenocarcinoma
- Interventions
- Device: ExAblate 2100
- First Posted Date
- 2020-03-06
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 1
- Registration Number
- NCT04298242
- Locations
- 🇺🇸
Stanford Cancer Center, Stanford, California, United States
Transhepatic Versus Subcostal Views to Assess Inferior Vena Cava Variation in Pediatric Patients
Not Applicable
Not yet recruiting
- Conditions
- Inferior Vena Cava Abnormality
- Interventions
- Diagnostic Test: Ultrasound Analysis of Inferior Vena Cavae (IVC)
- First Posted Date
- 2020-03-06
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 100
- Registration Number
- NCT04298216
Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery
Early Phase 1
Completed
- Conditions
- Parotid Gland TumorSubmandibular Gland Tumor
- Interventions
- Drug: Alda-341
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2020-03-05
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 10
- Registration Number
- NCT04296266
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone
Phase 1
Withdrawn
- Conditions
- Castrate Resistant Prostate CancerProstate Cancer
- Interventions
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2021-08-12
- Lead Sponsor
- Stanford University
- Registration Number
- NCT04296578
© Copyright 2025. All Rights Reserved by MedPath